Click on image to view larger version.

Figure 2 The effects of SR141716A (circles, n = 25) on early survival after myocardial infarction; SR141716A given at 0 min. The rats were treated intravenously either with 6.45 µmol/kg SR141716A or vehicle (circles, n = 20) 15 min before experimental myocardial infarction. *Significant difference (p < 0.05) from corresponding value in vehicle-treated rats.